Difference between revisions of "Saillan-Barreau 2008 J Acquir Immune Defic Syndr"
From Bioblast
(Created page with "{{Publication |title=Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, Pénicaud L (2008) Drug-specific effect of nelfinavir and stavudine on primary culture of human preadi...") |
|||
| Line 1: | Line 1: | ||
{{Publication | {{Publication | ||
|title=Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, Pénicaud L (2008) Drug-specific effect of nelfinavir and stavudine on primary culture of human preadipocytes. J. Acquir. Immune Defic. Syndr. 48: 20-25. | |title=Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, Pénicaud L (2008) Drug-specific effect of nelfinavir and stavudine on primary culture of human preadipocytes. J. Acquir. Immune Defic. Syndr. 48: 20-25. | ||
|authors=Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, Penicaud L | |info=[http://www.ncbi.nlm.nih.gov/pubmed/18344876 PMID: 18344876] | ||
|authors=Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, Penicaud L | |||
|year=2008 | |year=2008 | ||
|journal=J. Acquir. Immune Defic. Syndr. | |journal=J. Acquir. Immune Defic. Syndr. | ||
| | |mipnetlab=FR_Toulouse_CasteillaL | ||
}} | }} | ||
{{Labeling | {{Labeling | ||
Revision as of 12:25, 12 November 2010
| Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, Pénicaud L (2008) Drug-specific effect of nelfinavir and stavudine on primary culture of human preadipocytes. J. Acquir. Immune Defic. Syndr. 48: 20-25. |
Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, Penicaud L (2008) J. Acquir. Immune Defic. Syndr.
Abstract:
• O2k-Network Lab: FR_Toulouse_CasteillaL
Labels:
Regulation: Respiration; OXPHOS; ETS Capacity"Respiration; OXPHOS; ETS Capacity" is not in the list (Aerobic glycolysis, ADP, ATP, ATP production, AMP, Calcium, Coupling efficiency;uncoupling, Cyt c, Flux control, Inhibitor, ...) of allowed values for the "Respiration and regulation" property.
HRR: Oxygraph-2k
